Early Antiretroviral Treatment and/or Early Isoniazid Prophylaxis Against Tuberculosis in HIV-infected Adults (ANRS 12136 TEMPRANO)

Principal Investigator(s):Xavier Anglaret & Serge Eholié
Objective:To assess the benefits and risks of early antiretroviral therapy in HIV infected adults in Abidjan, Cote d'Ivoire
Prevention Option(s):Treatment U=U
Study Design:Controlled, Open label, Randomized
Official Code: NCT00495651
Trial Sponsors: French National Agency for Research on AIDS and Viral Hepatitis
Start Date
End Date
March 31, 2008
December 31, 2014
Age range: 18 Years ↔ any
Population:Cisgender Men, Cisgender Women, People Living with HIV